Global University Venturing

GV, Mass General Brigham Ventures and Lonza helped Affinia Therapeutics raise $110m to commercialise work originating at Harvard.

CU Boulder’s solid-state battery provider pulled in funding through a series B round co-led by potential customers BMW and Ford.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.

Ahren Innovation Capital has helped bring Zoe’s overall financing to $53m by leading a series B round for the personalised nutrition service.

Harvard University’s endowment has participated in a funding round for the robo-advisory platform.

Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.

NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Oxford University Innovation has revealed it launched 37 new companies between April 2020 and March 2021, its best run yet.

Diarmuid O’Brien will take over as chief executive of Cambridge Enterprise this September following the retirement of Tony Raven.